Aug 31, 2026 07:54AM
Aug 10, 2026 06:52AM
Aug 5, 2026 04:07PM
Jun 4, 2026 08:02AM
Apr 30, 2026 04:30PM
Apr 30, 2026 07:55AM
Apr 30, 2026 07:55AM Emergent BioSolutions Receives Approval from Singapore Health Sciences Authority for Expanded Indication of ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) to Include Mpox
Apr 29, 2026 07:25AM
Apr 28, 2026 08:01AM
Apr 28, 2026 08:01AM
Apr 7, 2026 12:42PM
Apr 7, 2026 08:05AM
Mar 25, 2026 04:15PM
Mar 25, 2026 04:15PM Emergent BioSolutions Secures over $60 Million in New Contract Award with the U.S. Government and New Orders with an International Government Partner for Smallpox Medical Countermeasures
Feb 26, 2026 04:05PM
Feb 12, 2026 06:00PM
Feb 12, 2026 06:00PM
Dec 12, 2025 08:30AM
Dec 12, 2025 08:30AM
Nov 18, 2025 08:01AM
Nov 18, 2025 08:00AM Emergent BioSolutions Marks 10-Year Anniversary of the U.S. FDA Approval of NARCAN® Nasal Spray and Reinforces its Commitment to Increasing Naloxone Access
Oct 29, 2025 04:15PM
Sep 24, 2025 04:05PM
Sep 16, 2025 06:57AM
Sep 15, 2025 08:36AM
Sep 15, 2025 08:35AM
Sep 11, 2025 06:49AM
Sep 9, 2025 07:31AM Emergent BioSolutions gets $56 million U.S. contract for smallpox vaccine
Sep 9, 2025 07:30AM
Sep 3, 2025 06:49AM
Aug 29, 2025 08:05AM
Aug 21, 2025 08:45AM
Aug 6, 2025 04:15PM
Jul 28, 2025 08:50AM
Jul 2, 2025 04:05PM Emergent BioSolutions (EBS) Expands NARCANDirect to Offer KLOXXADO Nasal Spray 8 mg and Convenience Kits Amid Changes in Overdose Death Rate
Jul 2, 2025 04:05PM
Jun 18, 2025 08:45AM
Jun 5, 2025 07:00AM
Jun 5, 2025 07:00AM
May 7, 2025 04:05PM
May 1, 2025 05:07PM
Mar 20, 2025 08:06AM Hikma announces Health Canada approval of KLOXXADO® (naloxone HCl) Nasal Spray 8 mg
Mar 13, 2025 08:29AM
Mar 10, 2025 09:15AM
Mar 10, 2025 09:14AM
Mar 3, 2025 04:23PM
Feb 7, 2025 08:06AM
Jan 21, 2025 06:45AM
Jan 16, 2025 08:00AM Enrollment Starts in Africa CDC-Led MpOx Therapeutic Study (MOSA)
Jan 14, 2025 07:31AM

330,004 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All